A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.

The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents ...

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol ...

A clinical stage biopharma firm in Miami is slashing its headcount after selling its female condom business to an investment ...

Kura Oncology Inc (KURA) stock saw a decline, ending the day at $8.51 which represents a decrease of $-0.16 or -1.85% from the prior close of $8.67. The stock opened at $8.65 and touched a low of ...

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and ...

RIL's biggest acquisition in the last five years has been buyout of local cable TV and internet service providers Hathway ...

With women being diagnosed with cancer at younger ages, doctors are working to avoid that diagnosis altogether. Genetic ...

Toronto-based private equity firm Birch Hill Equity Partners has completed its acquisition of the Rexall Pharmacy Group.

As we step into January 2025, global markets have been marked by a mix of moderate gains and economic uncertainties, with U.S. consumer confidence showing signs of decline and European growth ...

The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with ...